We are a clinical coordinating center working to expand scientific knowledge and improve public health through clinical trials and epidemiologic research.
Our partners at CDISC put together a wonderful video on the T1-DEXI study and the importance of interoperable data sharing, a great example of collaborative work to further expand our knowledge of type 1 diabetes! https://t.co/U2EB9kD6oY
JAEB founder and Medical Director Dr. Roy W. Beck was honored to receive the 2026 Mary Tyler Moore and S. Robert Levine M.D. excellence in Clinical Research Award from BreakthroughT1D for his leadership and achievements in T1D research last night! https://t.co/J9iowdOqI3
JAEB is thrilled to have two presentations at the inaugural Breakthrough T1D Clinical & Research Congress this weekend in Philadelphia, stop by if you are in the City of Brotherly Love!
An analysis from the DEKS trial found that donor endothelial cell damage, intraoperative complications, and recipient diagnosis other than FECD were linked to greater endothelial cell loss at 1 year. ✏️coauthor GCDTR’s Roy Beck (@JaebCenter).
🔗https://t.co/l5EzZTkXI6
Results from the ANCHOR study, a meta-analysis of 8 different clinical trials examining the relationship of L2 hypoglycemic events and overall time spent <54 mg/dL, were published earlier this month in Diabetes Technology & Therapeutics; https://t.co/ttgz5fNUdJ
Dr. Camille Powe will be hosting an AMA on the PRAM-T1D Study on July 22 from 3–4 PM ET, check out the link below for more details!
https://t.co/E2nslGrkss
We are looking for people living with type 1 diabetes, age 18 and older, to join an online study to help us learn more about how education can help with blood sugar management when you exercise. Learn more EDGE today! https://t.co/7O6phqPkpO
EDGE is recruiting adults with type 1 diabetes for an online study to see how education could make diabetes management easier when you exercise. Want to learn more and see if you qualify? Click here to learn more about the EDGE study: https://t.co/7O6phqPkpO
If you have been living with type 1 diabetes for at least 1 year and are 18 or older, we want to hear from you! Learn more about our online educational study on exercise today: https://t.co/7O6phqPkpO
This #NationalVolunteerWeek, we want to highlight our 2026 Federal Advocate of the Year, Dr. Henry Rodriguez!
Learn more about his outstanding commitment, leadership, and tireless advocacy on behalf of people living with diabetes across the US: https://t.co/DcFSB4gSgv
The latest study from PEDIG on full-time alternate day patching in treating intermittent exotropia in children came out earlier this month! https://t.co/GYQngi8vCx
A recent review published in JAMA authored by GCDTR’s @JacobsenLM and Desmond A. Schatz highlights key advances in understanding autoimmune mechanisms, early detection, and evolving treatment strategies.
https://t.co/lJxS36s3T5
Primary results from the CALEC study were published in March of last year and still generating plenty of interest, check out this write up in Nat Geo!
https://t.co/7bQqm2aign